Exclusive: Valeant, Actavis, Mylan eye Pfizer's generics unit

14-01-2014 Reuters UKComments (0)


According to the people close to the matter, Pfizer is aware of each of the companies' interest but is not yet ready to entertain a deal as it prepares the groundwork for a potential separation of the generics business. It has said the review could ...

Read more on Reuters UK

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top